Home › Compare › EMOR vs BTI

EMOR vs BTI: Dividend Comparison 2026

EMOR yields 5000.00% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMOR wins by $62217131802825.31M in total portfolio value
10 years
EMOR
EMOR
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full EMOR calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — EMOR vs BTI

📍 EMOR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMORBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMOR + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMOR pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMOR
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, EMOR beats the other by $50,882,683,244,271,480,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMOR + BTI for your $10,000?

EMOR: 50%BTI: 50%
100% BTI50/50100% EMOR
Portfolio after 10yr
$31108565901412.70M
Annual income
$29,930,990,143,689,105,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

EMOR
No analyst data
Altman Z
-337.8
Piotroski
4/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMOR buys
0
BTI buys
0
No recent congressional trades found for EMOR or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMORBTI
Forward yield5000.00% ✓5.40%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$62217131802825.35M ✓$37.8K
Annual income after 10y$59,861,980,287,378,210,000.00 ✓$2,802.29
Total dividends collected$62057786341622.61M ✓$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: EMOR vs BTI ($10,000, DRIP)

YearEMOR PortfolioEMOR Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$510,700$500,000.00$11,301$601.08+$499.4K → EMOR
2$24,410,935$23,864,485.98$12,799$706.58+$24.40M → EMOR
3$1,092,192,501$1,066,072,800.30$14,527$832.38+$1092.18M → EMOR
4$45,746,366,951$44,577,720,975.17$16,527$982.75+$45746.35M → EMOR
5$1,793,932,828,410$1,744,984,215,772.56$18,846$1,162.95+$1793932.81M → EMOR
6$65,871,973,805,320$63,952,465,678,921.49$21,545$1,379.49+$65871973.78M → EMOR
7$2,265,146,887,602,700$2,194,663,875,631,007.20$24,694$1,640.41+$2265146887.58M → EMOR
8$72,954,689,148,998,180$70,530,981,979,263,280.00$28,378$1,955.69+$72954689148.97M → EMOR
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$32,702$2,337.79+$2201076182660.85M → EMOR
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$37,794$2,802.29+$62217131802825.31M → EMOR

EMOR vs BTI: Complete Analysis 2026

EMOR — Stock

Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other. Healixa Inc. also operates digital pharmacy marketplace. The company was formerly known as Emerald Organic Products Inc. and changed its name to Healixa Inc. in April 2021. The company was founded in 1977 and is based in Holbrook, New York.

Full EMOR Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this EMOR vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMOR vs SCHDEMOR vs JEPIEMOR vs OEMOR vs KOEMOR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.